Moneycontrol PRO
thyrocare technologies
Jump to
98 Results Found
  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher Aug 21, 2018 05:04 PM IST

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated August 14, 2018.

  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher Aug 10, 2018 03:49 PM IST

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated August 06, 2018.

  • Buy Thyrocare Technologies; target of Rs 750: Edelweiss May 16, 2018 06:55 PM IST

    Buy Thyrocare Technologies; target of Rs 750: Edelweiss

    Edelweiss is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 750 in its research report dated May 03, 2018.

  • Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher May 16, 2018 06:50 PM IST

    Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 795 in its research report dated May 04, 2018.

  • Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss Apr 17, 2018 07:13 PM IST

    Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss

    Net Sales are expected to increase by 15 percent Y-o-Y (up 20.3 percent Q-o-Q) to Rs. 100.9 crore, according to Edelweiss.

  • See margins at 37-41% for coming qtrs; growth at 22% for next 2-3 years: Thyrocare Tech Feb 05, 2018 12:48 PM IST

    See margins at 37-41% for coming qtrs; growth at 22% for next 2-3 years: Thyrocare Tech

    Going forward for the next 2-3 years, the growth is expected at the rate of 22 percent, said A Velumani, Chairman, CEO and Managing Director, Thyrocare Technologies.

  • Buy Thyrocare Technologies; target of Rs 740: Edelweiss Dec 12, 2017 03:48 PM IST

    Buy Thyrocare Technologies; target of Rs 740: Edelweiss

    Edelweiss is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 12, 2017.

  • Norwest Venture sells 9.3% stake in Thyrocare for Rs 335 cr Aug 29, 2017 08:20 AM IST

    Norwest Venture sells 9.3% stake in Thyrocare for Rs 335 cr

    According to bulk deal data available with BSE, Norwest Venture Partners VII-A-Mauritius offloaded a total of 50 lakh shares, or 9.30 per cent stake, of Thyrocare Technologies.

  • Thyrocare to invest $100 million to expand nuclear medicine imaging biz Aug 14, 2017 09:41 PM IST

    Thyrocare to invest $100 million to expand nuclear medicine imaging biz

    Thyrocare's CEO and chairman Velumani is betting big on the imaging services as the next major revenue growth driver.

  • Would look to add 4 more regional processing labs, says Thyrocare Aug 14, 2017 10:45 AM IST

    Would look to add 4 more regional processing labs, says Thyrocare

    Thyrocare Technologies posted a good set of numbers this quarter. In an interview to CNBC-TV18, A Velumani, Chairman, MD & CEO of Thyrocare Technologies discussed the company's Q1 performance.

  • Wellness segment contributes majority of growth: Thyrocare's Velumani Jun 02, 2017 04:18 PM IST

    Wellness segment contributes majority of growth: Thyrocare's Velumani

    In an interview to CNBC-TV18, A Velumani, Chairman, CEO & MD of Thyrocare Technologies spoke about the results and his outlook for the company.

  • Traders Carnival: Watch A Velumani's rags to riches story May 09, 2017 08:52 AM IST

    Traders Carnival: Watch A Velumani's rags to riches story

    Watch A Velumani, Chairman and MD, Thyrocare sharing his rags to riches story at Traders Carnival 2017.

  • Luxury of Poverty: The making of Chennai Silks Mar 22, 2017 08:14 AM IST

    Luxury of Poverty: The making of Chennai Silks

    Luxury of Poverty focuses on the brave hearts who have won against all odds and stories that inspire people to become entrepreneurs. Dr A Velumani of Thyrocare Technologies is a perfect role model and so in many ways is better placed to comment and give views on entrepreneur's features. Luxury of Poverty focuses on The Chennai Silks, one of the largest retail outlet that sells sarees, dress materials and men's wear for over five decades.

  • Avenue Supermarts shines bright among stocks with listing day gains; 5 stocks which gave bumper listing in FY17 Mar 21, 2017 11:29 AM IST

    Avenue Supermarts shines bright among stocks with listing day gains; 5 stocks which gave bumper listing in FY17

    Avenue Supermarts, the operator of supermarket retail chain D-Mart on Tuesday, more than doubled investors’ wealth on debut itself.

  • Luxury of Poverty: Take a look at Balaji Wafers' story Mar 06, 2017 08:25 AM IST

    Luxury of Poverty: Take a look at Balaji Wafers' story

    Thyrocare Luxury of Poverty focuses on Chandubhai Virani, the man who built Balaji Wafers. It is a hard-earned success story. Chandubhai started as a gate-keeper at a cinema theatre in Rajkot some four decades ago. Today he has built a brand that is giving big players sleepless nights.

  • The Luxury of Poverty: Know more about Thyrocare's A Velumani Feb 20, 2017 04:48 PM IST

    The Luxury of Poverty: Know more about Thyrocare's A Velumani

    Know more about the Chairman of Thyrocare Technologies, Dr A Velumani in this of episode of - The Luxury of Poverty-Winning against all odds.

  • Dilip Bhat positive on pharma sector Feb 17, 2017 05:06 PM IST

    Dilip Bhat positive on pharma sector

    Dilip Bhat of Prabhudas Lilladher is positive on the pharma sector largely because of the growth factor and because of the profitabilities.

  • Bhel, Idea to move out of Nifty 50 from Mar 31 Feb 16, 2017 07:40 PM IST

    Bhel, Idea to move out of Nifty 50 from Mar 31

    State-run BHEL and telecom major Idea Cellular will move out of National Stock Exchange's Nifty 50 index from March 31.

  • Eris Lifesciences files IPO papers with Sebi Feb 10, 2017 12:40 PM IST

    Eris Lifesciences files IPO papers with Sebi

    "The company expects that listing of the equity Shares will enhance our visibility and brand image and provide liquidity to our shareholders. Listing will also provide a public market for the equity shares in India," Eris said in the draft documents.

  • Aim to sustain 25% topline growth in FY17: Thyrocare Jan 31, 2017 11:56 AM IST

    Aim to sustain 25% topline growth in FY17: Thyrocare

    Thyrocare Technologies is betting big on the radiology vertical which requires huge capex, but is capable of bringing in good business, says Chairman, CEO & MD A Velumani.

  • Stocks in news: Idea, ICICI Bank, Dilip, NMDC, Motilal Oswal Jan 31, 2017 08:00 AM IST

    Stocks in news: Idea, ICICI Bank, Dilip, NMDC, Motilal Oswal

    Idea Cellular | Maruti Suzuki | ICICI Bank | Dabur India | Dilip Buildcon | Pioneer Distilleries | IL&FS Transportation | Thyrocare | NMDC | SAIL | Emami | Bajaj Finserv | Dish TV | Dalmia Bharat Sugar | Emkay Global | Alankit | Indraprastha Medical and Motilal Oswal are stocks, which are in the news today.

  • Thyrocare chief sees a sales growth of 25% in third quarter Dec 22, 2016 01:00 PM IST

    Thyrocare chief sees a sales growth of 25% in third quarter

    Diagnostics company Thyrocare Technologies felt the blow of demonetisation in the month of November but was back on its feet and saw growth at 24 percent in the month under review.

  • Aurobindo's Hyd unit getting form 483 a non-event: Surajit Pal Dec 20, 2016 10:50 AM IST

    Aurobindo's Hyd unit getting form 483 a non-event: Surajit Pal

    USFDA has issued notice to the Hyderabad unit of Aurobindo Pharma and calming the nerves of the investors Surajit Pal of Prabhudas Lilladher says that it is a non-event and there is no need to worry.

  • Buy Thyrocare Tech; target of Rs 1067: Prabhudas Lilladher Nov 21, 2016 05:31 PM IST

    Buy Thyrocare Tech; target of Rs 1067: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 1067 in its research report dated November 17, 2016.

  • Prefer SBI, Britannia, Reliance Capital: Dilip Bhat Oct 30, 2016 09:03 PM IST

    Prefer SBI, Britannia, Reliance Capital: Dilip Bhat

    Dilip Bhat, Joint MD at Prabhudas Lilladher is of the view that one may prefer SBI, Britannia Industries, Reliance Capital and Thyrocare.

Sections
ISO 27001 - BSI Assurance Mark